Treatment of mitral regurgitation

Submitted: May 17, 2017
Accepted: May 17, 2017
Published: July 18, 2017
Abstract Views: 1362
PDF: 645
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


In the elderly mitral regurgitation is very frequent and surgical correction of mitral regurgitation (MR) has often a high operative risk, consequently, over the years, different percutaneous transcatheter techniques have been developed as a valid alternative to surgery. The edge-to-edge repair with the MitraClip device has gained a wide clinical application, supported by several studies, both randomize trials and registries. It is indicated in functional MR as in degenerative MR. The outcome is usually positive, resulting in a reduction of the regurgitation to grade 1+ or 2+ and an improvement in the functional class to I or II reducing hospitalizations. Its cost-effectiveness too is supported by some studies.



PlumX Metrics


Download data is not yet available.


How to Cite

Violini, Roberto, Alberta Cifarelli, Francesco De Felice, and Diana Chin. 2017. “Treatment of Mitral Regurgitation”. Monaldi Archives for Chest Disease 87 (2).